Dr Richard Wyse is Director of Research and Development at The Cure Parkinson’s Trust (CPT). His role is to monitor scientific and medical developments into the causes and treatment of Parkinson’s disease to design and foster promising new lines of therapeutic research and to promote beneficial worldwide scientific and clinical collaborations across the Parkinson’s community. CPT’s…Read more

Read more

Dr. Shandler brings over a decade of various commercial and scientific operating experiences to Longevity. Prior to founding Longevity, Dr. Shandler was a venture capitalist at BioAdvance, an early stage fund based in Philadelphia, where he was responsible for therapeutics, diagnostic and biomarker opportunities. Prior to BioAdvance, Dr. Shandler was a portfolio analyst for Merck…Read more